Our results are in accordance with few previous studies that showed significant improvement of insulin sensitivity after anti-TNF therapy in patients with rheumatoid arthritis, psoriasis, and ankylosing spondylitis, especially in subgroups with higher insulin resistance [12–15, 17–20]. This evidence concerns the gene TNF and psoriasis.